YPrime Earns Prestigious EcoVadis Rating, Strengthening Commitment to Sustainable and Responsible Clinical Research
March 12, 2025 08:00 ET
|
Y-Prime, LLC
YPrime earns prestigious EcoVadis rating, reinforcing commitment to sustainable clinical research.
Politecnico di Torino flies to Ethiopia for an institutional mission
March 03, 2025 07:01 ET
|
Politecnico di Torino
The Turin’s technical University expands connections and networks with Ethiopia in line with its internationalization strategy, in which Africa is among the leading countries TURIN, Italy, March ...
Tiziana Life Sciences Announces Long Covid Study to Complete in Second Quarter
February 25, 2025 08:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
CEOs face personal inflection point affecting decision making, management and culture; seek to recalculate AI journey, CEO study finds
January 21, 2025 08:53 ET
|
The Futurum Group
Davos, Switzerland, Jan. 21, 2025 (GLOBE NEWSWIRE) --CEOs of established enterprises (10 years and up) sense internal paralysis despite owning richer historical data sets while emerging ‘digital...
The BPI Network and Growth Officer Council Launch Study to Examine Major Challenges Around Data AI Readiness
January 14, 2025 08:00 ET
|
CMO Council
Thought Leadership Initiative will Investigate How Prepared and Primed Organizations are to Unlock GenAI’s Next-Generation Business Value
Tiziana Announces Reduction of Side Effects Commonly Seen with Discontinuation of GLP-1 Agonists with Nasal Anti-CD3
January 10, 2025 08:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
Angitia Biopharmaceuticals Announces Dosing of First Patient in Phase 2 Clinical Trial of AGA2118 for the Treatment of Osteoporosis
November 04, 2024 07:30 ET
|
Angitia Incorporated Limited
WOODLAND HILLS, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Angitia Biopharmaceuticals, a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for...
No Evidence that Tampons Cause Metal Poisoning: American College of Medical Toxicology Issues Position Statement
October 14, 2024 15:21 ET
|
American College of Medical Toxicology
Phoenix, AZ, Oct. 14, 2024 (GLOBE NEWSWIRE) -- A recent paper by Shearston et al.,” Tampons as a source of exposure to metal(loid)s,” revealed their testing had detected trace amounts of 16 metals...
Deepfake Fraud Doubles Down: 49% of Businesses Now Hit by Audio and Video Scams, Regula’s Survey Reveals
September 30, 2024 07:00 ET
|
Regula
According to the Regula Deepfake Trends 2024 study, one in two businesses globally reported incidents of deepfake fraud.
TechSmith’s 2024 Video Viewer Study Finds 75% of People Are Receptive to AI-generated Video Content But Not Without Concerns
September 11, 2024 09:00 ET
|
TechSmith Corporation
TechSmith released its 2024 Video Viewer Study, which examines global viewer engagement and preferences of instructional and informational video content.